MIA-T Percutaneous Tricuspid Annuloplasty System
Tricuspid Regurgitation
Clinical TrialActive
Key Facts
About Micro Interventional Devices
Micro Interventional Devices is a private, pre-revenue medical device company developing a disruptive platform for transcatheter cardiac repair. Its core technology is the proprietary PolyCor anchoring system, which enables percutaneous annuloplasty procedures for treating tricuspid and mitral regurgitation. The company's lead product, the MIA-T system for tricuspid valve repair, has FDA Breakthrough Device designation and is in clinical trials, while the mitral system, MIA-M, anticipates first-in-human use in 2024. MID aims to transform structural heart disease treatment by offering surgical efficacy with the safety of a catheter-based approach.
View full company profileTherapeutic Areas
Other Tricuspid Regurgitation Drugs
| Drug | Company | Phase |
|---|---|---|
| Tricuspid Valve Repair System | Abbott | Clinical Investigation |
| MonarQ TTVR System | Peijia Medical | Global Clinical Trial |